Analysis Bonus BioGroup Ltd. (BBIXF)
5/29/2024
Analysis of Bonus BioGroup Ltd. (BBIXF)
Bonus BioGroup Ltd. (BBIXF) has shown consistent trading at a price of 0.04 over the past few days. The Relative Strength Index (RSI) indicator is quite high at 73.23, indicating that the stock may be overbought.Looking at the Moving Average Convergence Divergence (MACD) indicator, we see that the MACD line is positive, above the signal line, and the MACD histogram is also positive. This suggests a bullish trend in the stock price.
The Moving Average (MA) indicator is also positive, with the Simple Moving Average (SMA), Exponential Moving Average (EMA), and Weighted Moving Average (WMA) all showing an upward trend.
Overall, based on the technical indicators, Bonus BioGroup Ltd. seems to be in a bullish phase, but investors should be cautious of the high RSI value, which may indicate a potential reversal in the stock price.
Revenue estimate
Based on the analysts' estimates for the future quarterly and annual sales of the company, we can draw the following conclusions:1. For the current quarter ending on June 30, 2024, the average sales estimate is $83,776,900,000, with a sales growth of 2% compared to the same quarter last year. The number of analysts providing estimates is 24.
2. For the next quarter ending on September 30, 2024, the average sales estimate is $92,375,300,000, with a sales growth of 3% compared to the same quarter last year. The number of analysts providing estimates is 24.
3. For the current fiscal year ending on September 30, 2024, the average sales estimate is $386,681,000,000, with a sales growth of 1% compared to the previous fiscal year. The number of analysts providing estimates is 37.
4. For the next fiscal year ending on September 30, 2025, the average sales estimate is $411,555,000,000, with a sales growth of 6% compared to the current fiscal year. The number of analysts providing estimates is 37.
These estimates suggest a moderate growth trend in both quarterly and annual sales for the company, with slightly higher growth expected in the next fiscal year compared to the current one.
Growth estimates
Based on the consensus estimates provided, we can draw the following conclusions regarding the growth rate of the company for different periods:1. Current Quarter: The estimated growth rate for the current quarter is 5.6%.
2. Next Quarter: The estimated growth rate for the next quarter is 4.8%.
3. Current Year: The estimated growth rate for the current year is 7.5%.
4. Next Year: The estimated growth rate for the next year is 9.7%.
5. Past 5 Years (per annum): The average growth rate for the past 5 years is 20.1%.
6. Next 5 Years (per annum): The estimated growth rate for the next 5 years is 11%.
These estimates suggest a positive growth trend for the company, with a slightly lower growth rate expected in the next 5 years compared to the past 5 years. The company is projected to experience steady growth in the short term, with a higher growth rate expected in the next year compared to the current year.
Price target
Based on the analysts' forecast, the future price of the security is expected to range between $164 (low) and $250 (high), with a median estimate of $200 and an average estimate of $202.26. The current price of the security is $191.57.Earnings
The company's results for the most recent quarter, ending on April 30, 2025, have not been provided yet. The previous results, ending on February 27, 2025, were handled by the Transfer Agent. The results for January 31, 2025, were released after hours. The results for October 31, 2024, were not provided at a specific time. The results for August 1, 2024, showed an earnings per share (EPS) estimate of 1.32.Main Statystic ðŸ§
The data provided includes financials, stock statistics, valuation metrics, stock price summary, and dividends and splits information for a specific company.In terms of financials, the company has strong operating cash flow and levered free cash flow, with a positive profit margin and healthy return on assets and equity. The balance sheet shows a decent current ratio, but a relatively high total debt to equity ratio. The income statement indicates significant revenue and EBITDA, with a good gross profit margin and earnings per share.
Moving on to stock statistics, the company has a low short ratio and a significant percentage of shares held by institutions. The stock price summary shows the stock's performance over the past year, including its beta, moving averages, and the range between its fifty-two-week low and high.
Valuation metrics reveal the company's price-to-earnings ratios, price-to-book ratio, and enterprise value multiples. The market capitalization is also provided.
Lastly, dividends and splits information includes details on dividend rates, payout ratios, dividend yield, and historical split data for the company's stock.
Income statement 💸
Here are the revenue figures for the company over the past four fiscal years:- 2020: $274,515,000,000
- 2021: $365,817,000,000
- 2022: $394,328,000,000
- 2023: $383,285,000,000
From these numbers, we can observe the following trends:
1. There was a steady increase in revenue from 2020 to 2022, with a slight decrease in 2023.
2. The company experienced significant growth in revenue between 2020 and 2022, indicating positive performance.
3. The slight decrease in revenue in 2023 could be a result of various factors such as market conditions, competition, or internal changes within the company.
4. Overall, the company has shown resilience and growth in its revenue over the past four years, positioning it well in the market.
Balance Sheet
These are balance sheets. Here are the conclusions based on the data provided:1. The total assets have been increasing over the years, indicating growth in the company's overall value.
2. Current assets fluctuate slightly from year to year, with variations in cash, inventory, and receivables.
3. Non-current assets show a general upward trend, mainly driven by investments and advances.
4. Total liabilities have also been increasing, but at a slower pace compared to total assets.
5. Shareholders' equity has shown some fluctuations, but overall it has been increasing steadily.
6. The company has been relying more on non-current liabilities, such as long-term debt, to finance its operations.
7. The company seems to have a stable financial position with a healthy mix of assets, liabilities, and equity.
Cash Flow 💶
This is the cash flow statement. Here are some conclusions we can draw from the data:1. The company's free cash flow has been fluctuating over the years, with the highest value recorded in 2022 and the lowest in 2020.
2. Operating cash flow has generally been increasing year over year, indicating improved operational efficiency.
3. Financing activities have a significant impact on the company's cash position, with large amounts being used for common stock repurchase and debt issuance.
4. Investing activities show a mix of acquisitions, investments, and capital expenditures, with varying levels of cash flow impact each year.
5. Interest paid and income tax paid have also varied over the years, affecting the company's overall cash flow position.
6. The end cash position has been fluctuating, but the company has maintained a healthy cash reserve throughout the years.
Earnings estimate
The analysts' estimates for future quarterly and annual earnings per share are as follows:1. Current Quarter (as of June 30, 2024):
- Average Estimate: $1.33
- Low Estimate: $1.27
- High Estimate: $1.36
- Year Ago EPS: $1.26
- Number of Analysts: 26
2. Next Quarter (as of September 30, 2024):
- Average Estimate: $1.53
- Low Estimate: $1.44
- High Estimate: $1.63
- Year Ago EPS: $1.46
- Number of Analysts: 25
3. Current Year (as of September 30, 2024):
- Average Estimate: $6.59
- Low Estimate: $6.43
- High Estimate: $6.92
- Year Ago EPS: $6.13
- Number of Analysts: 39
4. Next Year (as of September 30, 2025):
- Average Estimate: $7.23
- Low Estimate: $6.40
- High Estimate: $7.90
- Year Ago EPS: $6.59
- Number of Analysts: 39
Based on these estimates, we can see a generally positive trend in the expected earnings per share for both the upcoming quarters and the next two years. The average estimates are showing an increase compared to the year-ago EPS figures, indicating potential growth in earnings for the company.
MACD of BBIXF
This is not investment advice. Remember to verify the information provided here.
Get access to the full analysis
- Over 35 000 indexes
- CFD, Forex, Crypto and Stocks Exchange
- Over 150 Indicators
- Pattern and candle analysis
- Support and resistance levels
- Fundamental, technical and sentimental analysis
- Power from AI
